Core harm outcome sets developed by drug are needed to allow informed risk-benefit decision making

Documenti analoghi

• Usability and consistency of harm information in drug product descriptions: a matched comparison of data between the United States (US) and Europe
  di: Cornelius, Victoria R, et al.
  Pubblicazione: (2015)
• Making core outcomes more clinically meaningful: 2-for-the-price-of-1 with a distributional approach
  di: Peacock, Janet L, et al.
  Pubblicazione: (2015)
• Making decisions about benefits and harms of medicines
  di: Greenhalgh, Trisha, et al.
  Pubblicazione: (2004)
• Making continuous outcomes meaningful to clinicians
  di: Peacock, Janet L, et al.
  Pubblicazione: (2011)
• Variation in adverse drug reactions listed in product information for antidepressants and anticonvulsants, between the USA and Europe: a comparison review of paired regulatory documents
  di: Cornelius, Victoria R, et al.
  Pubblicazione: (2016)